Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
about
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrinsInteraction of endostatin with integrins implicated in angiogenesisPhysiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrinAntiangiogenic gene therapy of cancer: recent developmentsMicrovascular complications and diabetic retinopathy: recent advances and future implicationsDevelopments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitorsFamily Wide Molecular Adaptations to Underground Life in African Mole-Rats Revealed by Phylogenomic Analysis.Extracellular Matrix, a Hard Player in AngiogenesisPivotal role for decorin in angiogenesisHuman alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyMolecular imaging of vessels in mouse models of disease.Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesivenessCorrelating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system.Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.Matrilin-1 is an inhibitor of neovascularization.Molecular mediators of angiogenesis.Extracellular matrix modulates angiogenesis in physiological and pathological conditions.Characterization of a non-fibrillar-related collagen in the mollusc Haliotis tuberculata and its biological activity on human dermal fibroblasts.Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.Matrix metalloproteinase control of capillary morphogenesis.Effects of recombinant human canstatin protein in the treatment of pancreatic cancerRegulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.Lumican reduces tumor growth via induction of fas-mediated endothelial cell apoptosis.Mast cells and angiogenesis.Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapyT-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via alphavbeta3 and alpha5beta1 integrins.New functional roles for non-collagenous domains of basement membrane collagensCollagen type IV at the fetal-maternal interface.Cellular actions and signaling by endostatin.Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.The role of type IV collagen and basement membranes in cancer progression and metastasis.Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.Tumor angiogenesis as a target for dietary cancer preventionAngiogenesis: a curse or cure?Oncolytic virotherapy for pancreatic cancer.What the structure of angiostatin may tell us about its mechanism of action.Angiogenesis in non-small cell lung cancer. A new target for therapy.
P2860
Q24299560-7C0F0661-AF81-49C8-B812-BD19D017CBABQ24545535-782FC8E2-DA97-46B6-995F-B1A792BD2157Q24641850-E82ED5AE-C0B1-444B-9C97-6B4976D17F97Q24803786-59336198-1884-45EA-B171-A45EDE30DE5CQ26822476-ED27B555-E413-4890-BB0E-269D2044F6A1Q27004391-3DD413E4-5040-4328-AA7C-7D270D115824Q27300147-E68A0349-7147-4C8D-A2C2-4099F14A97CBQ28072886-8D791BB3-64DD-4DF3-8E12-7BCC2C2C3664Q28085303-4906D94A-9198-4A53-BC0C-3380768DF97EQ28271413-89CCF063-4AF6-4D7C-B278-DA8500C34882Q29040166-74818755-0E40-43C6-813E-A54EAAEEB00BQ30481645-C5D68F2F-262C-4D1F-B335-CFA307415C8AQ30524624-C36A89CD-BB43-46BD-BFAA-516928BAE594Q30896248-34D7B0E9-5641-4011-B16E-FD2DAEBBD604Q31058993-7563D97B-9D05-4D6E-BD67-9D1D725F88D0Q33237435-FD3CA636-F1E3-4448-B2D5-1F13E4293963Q33619544-55A3C8E9-C160-4A8C-B95F-76D5E8604FA7Q33639474-AFBF9600-1591-4364-9A28-61F94F25C795Q33737210-C279C0EA-C0E1-420A-98CC-2760692FFFCFQ33805033-45B5C5A3-2DFD-4241-A8DB-0CD8867C33CBQ33894448-8242F772-8DEA-485D-A41D-FF6A0E7810D7Q34002149-B462E5C1-E5E1-48E9-B2C9-5A05DCF7663EQ34017753-46F226C5-EC4D-463D-B8DC-602B75FF9DFAQ34230899-BAAAC07A-00AC-40C6-B030-450985E2074DQ34507203-E7061490-1740-4AE9-8945-C9B6D8B59F0DQ34619029-AE04884F-8C96-4070-B830-DFAC4ED733E2Q34698798-B5D3C740-1B78-4FBC-A4D2-8C6C26D94D68Q34732577-AFA6AAF8-1187-48BC-ACF9-2887156E820BQ34774929-3C09DA18-852D-43F5-93DA-A54D710E1EF1Q34958987-03D0C092-5BC6-479E-B124-16BC316C1211Q34996675-C61C8269-36C3-4CA7-B116-774422E4902EQ35008096-7502D40D-B850-4BED-831E-E617E1ECD9BDQ35083731-7B686470-A04B-4B18-9942-B1B672650A1AQ35088047-D621B606-B19E-476F-8330-D171AB49BE75Q35088057-B1F5F17E-E1E6-4B30-A441-865ACE581739Q35250910-C0AC31DB-B6E8-4CF8-BDF5-5DCC28C6486BQ35521647-DF1068C2-73A0-47A9-9826-116AF42A4E7AQ35590996-14583CAA-1440-4862-897D-D06B0BCD027DQ35626569-15A54D0E-F5A2-4732-B498-7D4828CD3FA3Q35627784-D0A58558-D4CE-4D80-8114-4BFF69E0FFC4
P2860
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@ast
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en-gb
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@nl
type
label
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@ast
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en-gb
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@nl
prefLabel
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@ast
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en-gb
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@nl
P2093
P356
P1476
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
@en
P2093
G D Kamphaus
P C Colorado
R Ramchandran
V P Sukhatme
Y Maeshima
P304
P356
10.1074/JBC.275.2.1209
P407
P577
2000-01-01T00:00:00Z